Yves Rosconi
Vorsitzender bei Laurent Pharmaceuticals, Inc.
Profil
Yves Rosconi is currently the Chairman at Laurent Pharmaceuticals, Inc. and a Director at Otsuka Canada Pharmaceutical, Inc. He previously worked as the President & Chief Executive Officer at Theratechnologies, Inc. from 2004 to 2010.
He also served as an Independent Director at Milestone Pharmaceuticals, Inc., Director at Verlyx Pharma, Inc., Chief Operating Officer at Æterna Zentaris, Inc., Senior Vice President at Sanofi, President & General Manager-Canadian Operations at Rhone Poulenc Rorer, and President & General Manager at Abbott Laboratories Co. Mr. Rosconi received his undergraduate degree from the University of Montréal and his MBA from HEC Montréal.
Aktive Positionen von Yves Rosconi
| Unternehmen | Position | Beginn |
|---|---|---|
Laurent Pharmaceuticals, Inc.
 Laurent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Laurent Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. The company was founded in 2012 and is headquartered in Montr?al, Canada. | Vorsitzender | - |
Otsuka Canada Pharmaceutical, Inc.
 Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Yves Rosconi
| Unternehmen | Position | Ende |
|---|---|---|
| THERATECHNOLOGIES INC. | Vorstandsvorsitzender | 01.12.2010 |
| SANOFI | Corporate Officer/Principal | - |
Abbott Laboratories Co.
 Abbott Laboratories Co. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Co. provides health care services. The firm conducts research and manufactures products for human health through every life stage. Its products include nutrition, diagnostics, vascular and diabetes care. The company is headquartered in Saint-Laurent, Canada. | Präsident | - |
Verlyx Pharma, Inc.
 Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Direktor/Vorstandsmitglied | - |
| AETERNA ZENTARIS INC. | Geschäftsführer | - |
Ausbildung von Yves Rosconi
| University of Montréal | Undergraduate Degree |
| HEC Montréal | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| THERATECHNOLOGIES INC. | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| AETERNA ZENTARIS INC. | Health Technology |
| SANOFI | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
Abbott Laboratories Co.
Abbott Laboratories Co. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Co. provides health care services. The firm conducts research and manufactures products for human health through every life stage. Its products include nutrition, diagnostics, vascular and diabetes care. The company is headquartered in Saint-Laurent, Canada. | Health Technology |
Laurent Pharmaceuticals, Inc.
Laurent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Laurent Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. The company was founded in 2012 and is headquartered in Montr?al, Canada. | Health Technology |
Otsuka Canada Pharmaceutical, Inc.
Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Health Technology |
